IMEMR
EMRO
66.92
Index Copernicus
ICICICICICICICIC
Volume 3, Issue 1 (2022)
J Clinic Care Skill 2022, 3(1): 13-18 |
Back to browse issues page
Article Type:
History
Received: 2021/12/18 | Accepted: 2022/03/12 | Published: 2022/03/12
Received: 2021/12/18 | Accepted: 2022/03/12 | Published: 2022/03/12
How to cite this article
Roustaei N, Hosayni H, Jokar S, Zinat Motlagh F. Factors Related to Medication Adherence in Hypertensive Patients in the Iranian Population. J Clinic Care Skill 2022; 3 (1) :13-18
URL: http://jccs.yums.ac.ir/article-1-121-en.html
URL: http://jccs.yums.ac.ir/article-1-121-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
2- Health Faculty, Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
2- Health Faculty, Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
Abstract (1670 Views)
Aims: Medication adherence is one of the most important concepts in the field of physical diseases, including hypertension. Many patients do not adhere to the treatment and ignore the doctor's instructions, which can cause many economic, physical, and cultural problems for the individual, family, and society. This study aimed to investigate the factors related to mediation adherence using social cognitive theory in hypertensive patients.
Instrument & Methods: This descriptive-analytical study was carried out on 112 patients (male and female) with hypertension in Yasuj, Iran in 2020. Data collection tools included the demographic information questionnaire, the Maurice therapy adherence questionnaire, and the bandura social theoretical constructs questionnaire (including self-efficacy, social support, and self-regulatory constructs). the collected data were analyzed using SPSS 22 software.
Findings: The rate of treatment adherence was 46.4% among patients (55.6% for men and 40.3% for women). There was a statistically significant relationship between age, education, and adherence to treatment (p<0.0001). The self-efficacy self-regulatory constructs predicted 22% of the variance in treatment adherence.
Conclusion: The results of this study showed that medication adherence in hypertensive patients referred to medical centers in Yasuj is at a weak level. Due to the correlation between the constructs of social cognitive theory and mediation adherence, the constructs of this theory can be used in adherence to treatment in patients with hypertension.
Instrument & Methods: This descriptive-analytical study was carried out on 112 patients (male and female) with hypertension in Yasuj, Iran in 2020. Data collection tools included the demographic information questionnaire, the Maurice therapy adherence questionnaire, and the bandura social theoretical constructs questionnaire (including self-efficacy, social support, and self-regulatory constructs). the collected data were analyzed using SPSS 22 software.
Findings: The rate of treatment adherence was 46.4% among patients (55.6% for men and 40.3% for women). There was a statistically significant relationship between age, education, and adherence to treatment (p<0.0001). The self-efficacy self-regulatory constructs predicted 22% of the variance in treatment adherence.
Conclusion: The results of this study showed that medication adherence in hypertensive patients referred to medical centers in Yasuj is at a weak level. Due to the correlation between the constructs of social cognitive theory and mediation adherence, the constructs of this theory can be used in adherence to treatment in patients with hypertension.
Keywords:
References
1. Uchmanowicz B, Chudiak A, Uchmanowicz I, Rosińczuk J, Froelicher ES. Factors influencing adherence to treatment in older adults with hypertension. Clin Interv Aging. 2018;13:2425-41. [DOI:10.2147/CIA.S182881] [PMID] [PMCID]
2. Wolf M, Ewen S, Mahfoud F, Bohm M. Hypertension: History and development of established and novel treatments. Clin Res Cardiol. 2018;107(Suppl 2):16-29. [DOI:10.1007/s00392-018-1299-y] [PMID]
3. Falaschetti E, Mindell J, Knott C, Poulter N. Hypertension management in England: A serial cross-sectional study from 1994 to 2011. Lancet. 2014;383(9932):1912-9. [DOI:10.1016/S0140-6736(14)60688-7]
4. World Health Organization (WHO). Hypertension [Internet]. Geneva, Switzerland: World Health Organization; c2021 - [2020 May 11]. Available from: https://www.who.int/news-room/fact-sheets/detail/hypertension. [link]
5. Uchmanowicz I, Jankowska-Polanska B, Chudiak A, Szymańska-Chabowska A, Mazur G. Psychometric evaluation of the polish adaptation of the hill-bone compliance to high blood pressure therapy scale. BMC Cardiovasc Disord. 2016;16:87. [DOI:10.1186/s12872-016-0270-y] [PMID] [PMCID]
6. O'Brien E. The lancet commission on hypertension: Addressing the global burden of raised blood pressure on current and future generations. J Clin Hypertens (Greenwich).2017;19(6):564-8. [DOI:10.1111/jch.12998] [PMID] [PMCID]
7. "Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, et al. Awareness, Treatment and Control of Pre-hy-pertension and Hypertension among Adults in Iran. Arch Iran Med. 2016;19(7):456-64. [link]
8. Shah N, Shah Q, Shah AJ. The burden and high prevalence of hypertension in Pakistani adolescents: A meta-analysis of the published studies. Arch Public Health. 2018;76(1):20. [DOI:10.1186/s13690-018-0265-5] [PMID] [PMCID]
9. Tiruneh SA, Bukayaw YA, Yigizaw ST, Angaw DA. Prevalence of hypertension and its determinants in Ethiopia: A systematic review and meta-analysis. PloS one. 2020;15(12):e0244642. [DOI:10.1371/journal.pone.0244642] [PMID] [PMCID]
10. Ramakrishnan S, Zachariah G, Gupta K, Rao JS, Mohanan P, Venugopal K, et al. Prevalence of hypertension among Indian adults: Results from the great India blood pressure survey. Indian Heart J. 2019;71(4):309-13. [link]
11. Xiao L, Le C, Wang GY, Fan LM, Cui WL, LiuYN, et al. Socioeconomic and lifestyle determinants of the prevalence of hypertension among elderly individuals in rural southwest China: a structural equation modelling approach. BMC Cardiovas Disord. 2021;21(1):64. [DOI:10.1186/s12872-021-01885-y] [PMID] [PMCID]
12. Garies S, Hao S, McBrien K, Williamson T, Peng M, Khan NA, et al. Prevalence of hypertension, treatment, and blood pressure targets in Canada associated with the 2017 American College of Cardiology and American Heart Association Blood Pressure Guidelines. JAMA Netw Open. 2019;2(3):e190406. [DOI:10.1001/jamanetworkopen.2019.0406] [PMID] [PMCID]
13. Oori MJ, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi A, Gheshlagh RG. Prevalence of HTN in Iran: Meta-analysis of published studies in 2004-2018. Curr Hypertens Rev. 2019;15(2):113-22. [DOI:10.2174/1573402115666190118142818] [PMID] [PMCID]
14. Eghbali M, Khosravi A, Feizi A, Mansouri A, Mahaki B, Sarrafzadegan N. Prevalence, awareness, treatment, control, and risk factors of hypertension among adults: A cross-sectional study in Iran. Epidemiol Health. 2018;40:e2018020. [DOI:10.4178/epih.e2018020] [PMID] [PMCID]
15. Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: A meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019;21(4):1-13. [DOI:10.1007/s11906-019-0933-z] [PMID]
16. Katibeh M, Moghaddam A, Yaseri M, Neupane D, Kallestrup P, Ahmadieh H. Hypertension and associated factors in the Islamic Republic of Iran: A population-based study. East Mediterr Health J. 2020;26(3):304-14. [DOI:10.26719/emhj.19.042] [PMID]
17. Ebrahimi M, Heidari-Bakavoli AR, Mazidi M, Moohebati M, Azarpazhooh MR, Nematy M, et al. Prevalence of hypertension, pre-hypertension and undetected hypertension in Mashhad, Iran. Mediterr J Nutr Metab. 2016;9(3):213-23. [Persian] [DOI:10.3233/MNM-150046]
18. Khorsandi M, Fekrizadeh Z, Roozbahani N. Investigation of the effect of education based on the health belief model on the adoption of hypertension-controlling behaviors in the elderly. Clin Interv Aging. 2017;12:233-240. [DOI:10.2147/CIA.S117142] [PMID] [PMCID]
19. Oori MJ, Mohammadi F, Norouzi-Tabrizi K, Fallahi-Khoshknab M, Ebadi A. Prevalence of medication adherence in patients with hypertension in Iran: A systematic review and meta-analysis of studies published in 2000-2018. Arya Atheroscler. 2019;15(2):82-92. [DOI:10.2174/1573402115666190118142818] [PMID] [PMCID]
20. Heizomi H, Iraji Z, Vaezi R, Bhalla D, Morisky DE, Nadrian H. Gender differences in the associations between health literacy and medication adherence in hypertension: A population-based survey in heris county, Iran. Vasc Health Risk Manag. 2020;16:157-66. [DOI:10.2147/VHRM.S245052] [PMID] [PMCID]
21. Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: A meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019;21(4):27. [DOI:10.1007/s11906-019-0933-z] [PMID]
22. Mirzaei M, Mirzaei M, Bagheri B, Dehghani A. Awareness, treatment, and control of hypertension and related factors in adult Iranian population. BMC Public Health. 2020;20(1):667. [DOI:10.1186/s12889-020-08831-1] [PMID] [PMCID]
23. Burnier M. Managing 'resistance': Is adherence a target for treatment?. Curr Opin Nephrol Hypertens. 2014;23(5):439-43. [DOI:10.1097/MNH.0000000000000045] [PMID]
24. Conn VS, Ruppar TM, Chase JA, Enriquez M, Cooper PS. Interventions to improve medication adherence in hypertensive patients: Systematic review and meta-analysis. Curr Hypertens Rep. 2015;17(12):94. [DOI:10.1007/s11906-015-0606-5] [PMID] [PMCID]
25. Salas M, Hughes D, Zuluaga A, Vardeva K, Lebmeier M. Costs of medication nonadherence in patients with diabetes mellitus: A systematic review and critical analysis of the literature. Value Health. 2009;12(6):915-22. [DOI:10.1111/j.1524-4733.2009.00539.x] [PMID]
26. Gellad WF, Grenard J, McGlynn EA. A review of barriers to medication adherence: A framework for driving policy options. Santa Monica, CA: RAND Corporation; 2009. [link]
27. Molloy GJ, Graham H, McGuinness H. Adherence to the oral contraceptive pill: A cross-sectional survey of modifiable behavioural determinants. BMC Public Health. 2012;12(1):838. [DOI:10.1186/1471-2458-12-838] [PMID] [PMCID]
28. Conn VS, Enriquez M, Ruppar TM, Chan KC. Meta-analyses of theory use in medication adherence intervention research. Am J Health Behav. 2016;40(2):155-71. [DOI:10.5993/AJHB.40.2.1] [PMID] [PMCID]
29. Sanuade OA, Boatemaa S, Kushitor MK. Hypertension prevalence, awareness, treatment and control in Ghanaian population: Evidence from the Ghana demographic and health survey. PloS One. 2018;13(11):e0205985. [DOI:10.1371/journal.pone.0205985] [PMID] [PMCID]
30. Glanz K, Rimer BK, Viswanath K. editors. Health behavior and health education: Theory, research, and practice. 4th Edition. Hoboken, New Jersey: John Wiley & Sons; 2008. [link]
31. Fakhri A, Morshedi H, Mohammadi Zeidi I. Effectiveness of theory based education on medication adherence in older adults with hypertension. Jundishapur Sci Med J. 2017;16(2):161-74. [Persian] [link]
32. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AK, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. Iran J Rehabil Res Nurs. 2015;1(3):24-32. [Persian] [link]
33. House JS, Robbins C, Metzner HL. The association of social relationships and activities with mortality: Prospective evidence from the Tecumseh Community Health Study. Am J Epidemiol. 1982;116(1):123-40. [DOI:10.1093/oxfordjournals.aje.a113387] [PMID]
34. Warren-Findlow J, Seymour RB. Prevalence rates of hypertension self-care activities among African Americans. J Natl Med Assoc. 2011;103(6):503-12. [DOI:10.1016/S0027-9684(15)30365-5]
35. Alshahrani EH, Aljohani RS, Sahli AA, Alruwaili WS, Almohini IA, Almodaimegh H. adherence to treatment and level of satisfaction among saudi hypertensive patients: A multi-city study. Cureus. 2021;13(12):e20189. [DOI:10.7759/cureus.20189]
36. Gaili AA, Al-Ebraheem SQ, Metwali ZM, Abdalla N, Al-Akshar S. The relationship between knowledge and drug adherence in hypertensive patients: A cross sectional study in UAE. Am J Adv Drug Deliv. 2016;4(1):1-11. [link]
37. Lee HJ, Jang SI, Park EC. Effect of adherence to antihypertensive medication on stroke incidence in patients with hypertension: A population-based retrospective cohort study. BMJ Open. 2017;7(6):e014486. [DOI:10.1136/bmjopen-2016-014486] [PMID] [PMCID]
38. Pan J, Wu L, Wang H, Lei T, Hu B, Xue X, Li Q. Determinants of hypertension treatment adherence among a Chinese population using the therapeutic adherence scale for hypertensive patients. Medicine. 2019;98(27):e16116. [DOI:10.1097/MD.0000000000016116] [PMID] [PMCID]
39. Algabbani FM, Algabbani AM. Treatment adherence among patients with hypertension: Findings from a cross-sectional study. Clin Hypertens. 2020;26:18. [DOI:10.1186/s40885-020-00151-1] [PMID] [PMCID]
40. Zinat Motlagh SF, Chaman R, Sadeghi E, Eslami AA. Self-care behaviors and related factors in hypertensive patients. Iran Red Crescent Med J. 2016;18(6):e35805. [DOI:10.5812/ircmj.35805] [PMID] [PMCID]
41. Nguyen TP, Schuiling-Veninga CC, Nguyen TB, Vu TH, Wright EP, Postma MJ. Adherence to hypertension medication: Quantitative and qualitative investigations in a rural Northern Vietnamese community. PLoS One. 2017;12(2):e0171203. [DOI:10.1371/journal.pone.0171203] [PMID] [PMCID]
42. Yang S, He C, Zhang X, Sun K, Wu S, Sun X, et al. Determinants of antihypertensive adherence among patients in Beijing: Application of the health belief model. Patient Educ Couns. 2016;99(11):1894-900. [DOI:10.1016/j.pec.2016.06.014] [PMID]
43. World Health Organization (WHO). Adherence to long-term therapies: Evidence for action [Internet]. Geneva, Switzerland: World Health Organization; c2003 - [2020 May 11]. Available from: https://apps.who.int/iris/handle/10665/42682. [link]